GGrantIndex
← Leaderboards

Suzanne M. Michalek

University Of Alabama At Birmingham

$6,713,138
Attributed
$6,713,138
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $896.5K · FY200512
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$6,713,138 · 3

By mechanism

R01$4,196,327 · 2
U01$2,516,811 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Others in their field

Top investigators on “Streptococcus Mutans

Research focus

Streptococcus MutansCholera ToxinTissue /Cell CultureVaccine DevelopmentLaboratory MouseMucosal ImmunitySalmonella VaccinesEnzyme Linked Immunosorbent AssayBacterial AntigensDental Caries VaccineVector VaccineSalmonellaChimeric ProteinsT LymphocyteImmunoglobulin AImmunomodulatorsSalivaFlow CytometryBiotechnologyLipopolysaccharidesBacterial VaccinesDrug Administration Rate /DurationImmunogeneticsNonhuman Therapy Evaluation

Grant awards (20)

Genetically Engineered Oral Vaccines and Caries Immunity$330,190
R01 · FY2012 · DE · contact PI
Genetically Engineered Oral Vaccines and Caries Immunity$334,124
R01 · FY2011 · DE · contact PI
Genetically Engineered Oral Vaccines and Caries Immunity$344,458
R01 · FY2010 · DE · contact PI
Genetically Engineered Oral Vaccines and Caries Immunity$347,344
R01 · FY2009 · DE · contact PI
Development of a Mucosal Vaccine Against Francisella tularensis$537,940
U01 · FY2007 · AI · contact PI
Development of a Mucosal Vaccine Against F. tularensis$540,058
U01 · FY2006 · AI · contact PI
Development of a Mucosal Vaccine Against F. tularensis$539,191
U01 · FY2005 · AI
Genetically Engineered Oral Vaccines &Caries Immunity$357,272
R01 · FY2005 · DE
Development of a Mucosal Vaccine Against F. tularensis$600,023
U01 · FY2004 · AI
Genetically Engineered Oral Vaccines &Caries Immunity$306,731
R01 · FY2004 · DE
Genetically Engineered Oral Vaccines &Caries Immunity$41,718
R01 · FY2004 · DE
Genetically Engineered Oral Vaccines &Caries Immunity$306,731
R01 · FY2003 · DE
Development of a Mucosal Vaccine Against F. tularensis$299,599
U01 · FY2003 · AI
REGULATION OF IMMUNE RESPONSE IN THE ORAL CAVITY$251,667
R01 · FY2003 · DE
Genetically Engineered Oral Vaccines &Caries Immunity$306,731
R01 · FY2002 · DE
REGULATION OF IMMUNE RESPONSE IN THE ORAL CAVITY$245,778
R01 · FY2002 · DE
Genetically Engineered Oral Vaccines &Caries Immunity$306,731
R01 · FY2001 · DE
REGULATION OF IMMUNE RESPONSE IN THE ORAL CAVITY$240,061
R01 · FY2001 · DE
GENETICALLY ENGINEERED ORAL VACCINES AND CARIES IMMUNITY$242,280
R01 · FY2000 · DE
REGULATION OF IMMUNE RESPONSE IN THE ORAL CAVITY$234,511
R01 · FY2000 · DE